The dead ends are critical to avoid. Read blogs and research and understand, I am seeking clarification on trial below.
http://www.ncbi.nlm.nih.gov/pubmed/24957270
In my digging I found this study, I am digging deeply to comment as false hope tragic for pioneering cancer patients.
I emailing ashdown and coventry for comment. I will keep on trying crp, and other measures, I will do crp myself, but the devil is in the detail, and this goes to the heart of science based survival.
I am so glad this has been tested, but I still like the immune homeostasis theory.
With gods help we will find away.
As I have warned you about my own irrational hope, that I clutch at straws, so do others with good intentions, specifically fellow bloggers.
No substitute for focus, effort and desperation, all of which I am grateful for. Thankyou god.
Can you see the forest from the trees, lets agree to do our best, love god and live well.
As an aside, looking into antibody result from latest dc vaccine. Waiting on duderstat comment and details, its all in specifics vaccine design, that's why trials deadly as they are not personalised enough.
Even my closest friends struggling and all my highly specialized drs.
My survival tied to seeing the big picture, its my jigsaw, I fit the pieces together. Goodluck with your jigsaw.
Measured your specific antibody result. It is effectively zero. Either all endogenous antibody is sequestered by tumour target or there is no antibody remaining after the vaccination. Or of course there was little or no antibody generated in the vaccination. That would require MHC Class II using the conjugated peptide priming whereas Class I involving T-cell activation could be activated instead using the peptide priming. It depends largely on what the clinic did in processing.